UTHR stock benefits from Trump-era tariffs and onshoring.
2 reports, 1 independent
Updated Jul 22
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UTHR stock benefits from Trump-era tariffs and onshoring.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
- United Therapeutics completed facility construction in Minnesota and Texas and submitted an NDA to the FDA.
- Various financial institutions, including Royal Bank of Canada, Bank of America, Raymond James Financial, TD Cowen, Cantor Fitzgerald, and MarketBeat, issued rating and price target updates regarding United Therapeutics on July 10, 2026.
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Coverage
Newest first; wire copies grouped- Insider MonkeyUnited Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag We recently published 10 Most Undervalued Pharma Stocks To Buy Now. United Therapeutics Corporatio
- Insider MonkeyUBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR) United Therapeutics Corp. (NASDAQ:UTHR) is one of the 11 best debt-free stocks to invest in right now. The company boasts a stro